Maruishi Pharmaceutical Co., Ltd. - Transfer of shares in Meguro Institute Co., Ltd. to Teijin Ltd.
Leading Japanese law firm Nishimura & Asahi advised Maruishi Pharmaceutical Co., Ltd., a Japan-based pharmaceutical company, on its transfer of all shares in Meguro Institute Co., Ltd. to Teijin Ltd. [TSE: 3401], a Japan-based materials, healthcare, and information technology company.
The Nishimura & Asahi team advising Maruishi Pharmaceutical was led by partners Hiromune Usuki and Masanori Ban, supported by Hitomi Matsuda.
People
Masanori is known for his extensive experience in a wide range of legal matters in Myanmar, Bangladesh, Thailand, and other Asian countries. Masanori also has significant expertise in supporting matters in relation to Business and Human Rights. Masanori has worked as a secondee at local law firms in Singapore and Myanmar, and as an in-house lawyer at a major Japanese international electronics manufacturer. By leveraging his insight into Asian markets and industries, Masanori provides flexible and practical solutions to the challenges and difficulties that clients face in their daily business, as well as in regard to developing markets and new legal issues. Masanori also provides advice on domestic and international matters in a variety of legal fields, including M&A, joint ventures, and other corporate transactions, as well as financial transactions, labour matters, and restructuring transactions.
Hiromune specializes in domestic and cross-border M&A cases, including hostile takeovers defenses, and organizational restructuring. Hiromune also handles a wide range of compliance-related cases in different practice areas, such as accounting fraud and antitrust violation cases, fact-finding investigations by board members and various corporate authorities, and the establishment of prevention measures. In addition to his broad expertise in general corporate matters, Hiromune has been advising well-known Japanese listed and blue-chip companies on general corporate law cases such as data protection cases, corporate governance cases, and defense cases against shareholder activists. Based on this extensive experience, Hiromune is committed to providing comprehensive and practical solutions to support his clients aiming for further challenges and growth.